Inapill is developing 1st-in-class small molecule therapeutics targeting immune cell metabolism (immunometabolism) for improved treatment of inflammatory, autoimmune, and age-related diseases. Inapill was co-founded by Greg Timblin, Josh Farahzad, and the therapeutics team @ General Inception, and is a tenant at the Bakar BioEnginuity Hub & Bakar Bio Labs @ UC Berkeley.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 2625 Durant Ave, Berkeley,california 94704,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.inapill.com/
- HQ
- Berkeley, California
Inapill Questions
Inapill's website is https://www.inapill.com/
Inapill's LinkedIn profile is https://www.linkedin.com/company/inapill
Inapill has
1 employees.
View email and phone details for 1
employees at Inapill.
Inapill's industry is
Biotechnology Research
Inapill's top competitors are
Kopra Bio,
Cube Biotech,
Resvita Bio,
Lunar Therapeutics,
California Life Sciences (Cls),
Circular Genomics,
Simurx, Inc.,
Misogi Labs,
Kira Bio,
Voyant Bio.
Inapill's categories are Biotechnology Research
Inapill's founding year is 2023
